Arena Pharmaceuticals Recent News
Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
Short Interest in Vertex Rises, in Biogen Idec Falls
Short Interest in Vertex Rises, in Celgene Falls
Short Sellers Move into Celgene, Regeneron
Short Sellers Move Out of Amgen, Celgene, Pharmacyclics
Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences
Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)
Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)
Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)
Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)
Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)
Short Sellers Shy Away from Biotech Firms
Short Interest in Biotech Firms on the Rise
Dendreon, Pharmacyclics and Other Biotech Takeover Targets
Oppenheimer Reviews Arena Pharmaceuticals at the Quarter
Oppenheimer Raises EPS Estimate From $0.58 To $0.69 On ARNA
Hapoaliom Views Arena's Lorcaserin As Unapprovable
Arena Waiting On FDA Approval Of Lorcaserin